KNW

Know Labs, Inc. (KNW) | Rumor.io

Know Labs

KNW

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about KNW?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Aug 18

Know Labs, Inc. ($KNW) is being added to portfolios as it is considered undervalued, with some investors targeting a price of $1.50 or lower.
The company's management has been criticized for a recent move that allowed a key executive to convert his stock to a lower price, potentially resulting in a significant gain.
Some investors believe $KNW is due for a further price decline, with some predicting a drop to as low as $0.30 or $0.40.

Generated by AI

Sentiment

Of the messages about KNW that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	76.63% +62.71
Bearish	—	—	—	23.37% -62.71

Bullish· Aug 6

The company has a significant patent portfolio with over 300 patents, providing a strong intellectual property moat.
The infusion of $100 million will retire debt, provide working capital, and support the company's growth, making it an attractive investment opportunity.
The company has a strong team with a proven track record of building and scaling successful businesses, and is well-positioned to capitalize on the growing diabetes market.

Bearish· Jun 25

$KNW is likely to decline to $3.15 per share based on its current price trend.
Know Labs, Inc. may experience major dilution, making its stock price unlikely to hold above $1 per share.
The company's stock has already cut in half due to market manipulation, and its chart is looking horrible, with a potential break below $2.07 support.

Generated by AI

Topics

Of the messages about KNW that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	21.43%
Announcements	—	—	—	19.21%
Controversies	—	—	—	0.22%
Earnings	—	—	—	0%
Macro	—	—	—	19.4%
Technical Analysis	—	—	—	39.74%

Announcements· Aug 6

Know Labs, Inc. ($KNW) has announced the closing of a $125M strategic acquisition, with Greg Kidd and Know Labs' new ticker symbol changing to USBC next week.
As part of the deal, the company will retire its existing debt, redeem outstanding preferred equity, and provide working capital using $15 million in cash and 1,000 Bitcoin.
The company's corporate legal name will change to USBC, Inc., and its ticker symbol will change from KNW to USBC, unveiling a new vision centered on the USBC token, a U.S.-dollar denominated token leveraging digital identity and blockchain technology.

Technical Analysis· Jun 12

$KNW has been identified as a top watch and is expected to break through trend and local supply to begin the next leg higher.
A cup and handle formation is visible on the daily chart, with a potential range to $6 or $6.6.
The stock has been experiencing a three-day accumulation top breakout, with a bullish pennant forming on the 15-minute chart.

Generated by AI

Community

Of the messages about KNW, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	7.6%
Newcomers	—	—	—	92.4%

Aug 6

Newcomers to $KNW are excited about the company's innovative approach to diagnostics, using radio-frequency signals and AI to eliminate the need for needles, strips, and wearables.
The acquisition of $100 million in strategic funding is seen as a game-changer for $KNW, allowing the company to retire debt, provide working capital, and increase its market potential.
$KNW's low float and recent trading activity are attracting attention, with some investors anticipating a potential price surge following the company's announcement of a strategic acquisition and infusion of capital.

Generated by AI

Also Discussed

Investors talking about KNW also mention

#	Name	Attention
1	Regencell Bioscience Holdings LimitedRGC	0%new
2	ProKidney Corp. Class A Ordinary SharesPROK	0%0
3	BSLK - Bolt Projects Holdings, Inc.	——
4	AGM Group Holdings IncAGMH	0%0
5	LQR House Inc.YHC	0%+0
6	Nvni Group LimitedNVNI	0%0
7	Globavend Holdings LimitedGVH	0%0
8	AREB - American Rebel Holdings, Inc.	——
9	Super League Enterprise Inc.SLE	0.01%+0
10	Addentax Group Corp.ATXG	0%0

Know Labs, Inc.

Location

Social

What share of all stock conversation is about KNW?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Aug 18

Know Labs, Inc. ($KNW) is being added to portfolios as it is considered undervalued, with some investors targeting a price of $1.50 or lower.
The company's management has been criticized for a recent move that allowed a key executive to convert his stock to a lower price, potentially resulting in a significant gain.
Some investors believe $KNW is due for a further price decline, with some predicting a drop to as low as $0.30 or $0.40.

Generated by AI

Sentiment

Of the messages about KNW that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	76.63% +62.71
Bearish	—	—	—	23.37% -62.71

Bullish· Aug 6

The company has a significant patent portfolio with over 300 patents, providing a strong intellectual property moat.
The infusion of $100 million will retire debt, provide working capital, and support the company's growth, making it an attractive investment opportunity.
The company has a strong team with a proven track record of building and scaling successful businesses, and is well-positioned to capitalize on the growing diabetes market.

Bearish· Jun 25

$KNW is likely to decline to $3.15 per share based on its current price trend.
Know Labs, Inc. may experience major dilution, making its stock price unlikely to hold above $1 per share.
The company's stock has already cut in half due to market manipulation, and its chart is looking horrible, with a potential break below $2.07 support.

Generated by AI

Topics

Of the messages about KNW that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	21.43%
Announcements	—	—	—	19.21%
Controversies	—	—	—	0.22%
Earnings	—	—	—	0%
Macro	—	—	—	19.4%
Technical Analysis	—	—	—	39.74%

Announcements· Aug 6

Know Labs, Inc. ($KNW) has announced the closing of a $125M strategic acquisition, with Greg Kidd and Know Labs' new ticker symbol changing to USBC next week.
As part of the deal, the company will retire its existing debt, redeem outstanding preferred equity, and provide working capital using $15 million in cash and 1,000 Bitcoin.
The company's corporate legal name will change to USBC, Inc., and its ticker symbol will change from KNW to USBC, unveiling a new vision centered on the USBC token, a U.S.-dollar denominated token leveraging digital identity and blockchain technology.

Technical Analysis· Jun 12

$KNW has been identified as a top watch and is expected to break through trend and local supply to begin the next leg higher.
A cup and handle formation is visible on the daily chart, with a potential range to $6 or $6.6.
The stock has been experiencing a three-day accumulation top breakout, with a bullish pennant forming on the 15-minute chart.

Generated by AI

Community

Of the messages about KNW, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	7.6%
Newcomers	—	—	—	92.4%

Aug 6

Newcomers to $KNW are excited about the company's innovative approach to diagnostics, using radio-frequency signals and AI to eliminate the need for needles, strips, and wearables.
The acquisition of $100 million in strategic funding is seen as a game-changer for $KNW, allowing the company to retire debt, provide working capital, and increase its market potential.
$KNW's low float and recent trading activity are attracting attention, with some investors anticipating a potential price surge following the company's announcement of a strategic acquisition and infusion of capital.

Generated by AI

Know Labs

Social

Aug 18

Sentiment

Bullish· Aug 6

Bearish· Jun 25

Topics

Announcements· Aug 6

Technical Analysis· Jun 12

Community

Aug 6

Also Discussed

Know Labs, Inc.

Company Information

Location

Social

Aug 18

Sentiment

Bullish· Aug 6

Bearish· Jun 25

Topics

Announcements· Aug 6

Technical Analysis· Jun 12

Community

Aug 6

Also Discussed